HKSE:02509 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:02509 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Qyuns Therapeutics Co's current 3-Year Share Buyback Ratio was 0.00%.
The historical rank and industry rank for Qyuns Therapeutics Co's 3-Year Share Buyback Ratio or its related term are showing as below:
During the past 4 years, Qyuns Therapeutics Co's highest 3-Year Share Buyback Ratio was 0.00%. The lowest was 0.00%. And the median was 0.00%.
For the Biotechnology subindustry, Qyuns Therapeutics Co's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Qyuns Therapeutics Co's 3-Year Share Buyback Ratio falls into.
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Qyuns Therapeutics Co (HKSE:02509) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Thank you for viewing the detailed overview of Qyuns Therapeutics Co's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Tai Zhou Jian Xin Chuang Ye Tou Zi You Xian Gong Si | 2101 Beneficial owner | |
Hang Zhou Zhong Mei Hua Dong Zhi Yao You Xian Gong Si | 2101 Beneficial owner | |
Zhong Guo Yuan Da Ji Tuan You Xian Ze Ren Gong Si | 2201 Interest of corporation controlled by you | |
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Bei Jing Yuan Da Hua Chuang Tou Zi You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Hua Dong Yi Yao Gu Fen You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Qiu Jiwan | ||
Xu Qiu | ||
Hangzhou Quanyi Investment Management Partnership (general Partnership) | ||
Yu Guo'an | ||
Zhu Jing | ||
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership) | ||
Sheng Xi Tai |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.